Management of Isolated Hypertriglyceridemia

Risk Stratification and Assessment

Mild-to-moderate hypertriglyceridemia (150-499 mg/dL) increases atherosclerotic cardiovascular disease risk through triglyceride-rich lipoproteins and remnant cholesterol, even when other lipid parameters are normal 1, 3
Approximately 27% of adults have mild-to-moderately elevated triglycerides, most commonly due to overweight-obesity and diabetes mellitus 1, 3
Severe hypertriglyceridemia (≥500 mg/dL) significantly increases acute pancreatitis risk and requires immediate attention 2
The American Diabetes Association recommends intensifying lifestyle therapy and optimizing glycemic control for triglycerides ≥150 mg/dL 5
Non-HDL cholesterol captures the atherogenic cholesterol content of triglyceride-rich lipoproteins and should be evaluated alongside triglycerides 1, 3, 6

The American Academy of Family Physicians emphasizes that most hypertriglyceridemia is secondary and potentially reversible 8
Lifestyle factors such as obesity, physical inactivity, excessive alcohol intake, and diet high in refined carbohydrates can contribute to hypertriglyceridemia 4
Certain medications, including atypical antipsychotics, beta-blockers, thiazide diuretics, oral estrogens, bile acid resins, protease inhibitors, steroids, and tamoxifen, can also elevate triglycerides 4
Medical conditions such as poorly controlled diabetes mellitus, hypothyroidism, chronic kidney disease, and pregnancy can contribute to hypertriglyceridemia 4, 7

Confirm hypertriglyceridemia with a fasting lipid panel if initial nonfasting triglycerides are ≥400 mg/dL 6
Calculate non-HDL cholesterol to assess atherogenic particle burden 1, 6
For severe elevations without obvious cause, consider apolipoprotein B measurement and genetic testing, especially with family history 6, 4
The American Heart Association notes that 74% of patients with metabolic syndrome have triglycerides ≥150 mg/dL 7
Screen for metabolic syndrome components, including abdominal obesity, blood pressure ≥130/85 mmHg, fasting glucose ≥100 mg/dL, and HDL <40 mg/dL in men or <50 mg/dL in women 7, 4

For triglycerides 150-499 mg/dL, lifestyle modification, including weight loss, Mediterranean or DASH eating pattern, and moderate-to-high intensity physical activity, is recommended 5
Calculate 10-year ASCVD risk using pooled cohort equations for patients 40-75 years, and consider moderate-intensity statin for borderline or intermediate risk 6
For high-risk patients or those with diabetes, use moderate-to-high intensity statin 5
For triglycerides ≥500 mg/dL, immediate actions include fibrate therapy, drastic reduction of dietary fat and simple carbohydrates, and addressing all secondary causes urgently 8, 4
For triglycerides ≥1,000 mg/dL, consider fibrate therapy even without pancreatitis history, and monitor closely for pancreatitis development 2